We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
+1.65%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$2.13B
AUM Growth
+$94.5M
Cap. Flow
+$215M
Cap. Flow %
10.08%
Top 10 Hldgs %
77.62%
Holding
31
New
3
Increased
–
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
OPWR
OPOWER INC COM STK (DE)
OPWR
+$168M
2
TRIV
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
+$59.9M
3
AGRX
Agile Therapeutics
AGRX
+$159K

Top Sells

Rank Stock Value
1
HPTX
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
+$12.9M

Sector Composition

Rank Sector Weight
1 Healthcare 46.08%
2 Technology 21.26%
3 Communication Services 18.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GRPN icon
1
Groupon
GRPN
$1.05B
$360M 16.88%
2,717,579
– –
TSRO
2
DELISTED
TESARO, Inc.
TSRO
$307M 14.38%
9,854,255
– –
EPZM
3
DELISTED
Epizyme, Inc
EPZM
$201M 9.41%
6,446,089
– –
CVT
4
DELISTED
CVENT, INC.
CVT
$174M 8.18%
5,996,212
– –
OPWR
5
DELISTED
OPOWER INC COM STK (DE)
OPWR
$170M 7.96%
+8,997,290
New +$168M
SUPN icon
6
Supernus Pharmaceuticals
SUPN
$2.75B
$116M 5.42%
10,650,000
– –
CLVS
7
DELISTED
Clovis Oncology, Inc.
CLVS
$94.4M 4.43%
2,279,781
– –
RNA
8
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
$81.8M 3.84%
6,480,171
– –
FIO
9
DELISTED
FUSION-IO INC COM
FIO
$79.5M 3.73%
7,038,379
– –
CBIO
10
Crescent Biopharma
CBIO
$598M
$72.3M 3.39%
85,751
– –
HPTX
11
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$62.2M 2.92%
2,384,221
-500,000
-17% -$12.9M
TRIV
12
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
$61.4M 2.88%
+3,945,191
New +$59.9M
ITMN
13
DELISTED
INTERMUNE INC
ITMN
$59.2M 2.78%
1,341,000
– –
MM
14
DELISTED
MILLENNIAL MEDIA INC COM STK (DE)
MM
$41M 1.93%
8,224,752
– –
VIRX
15
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$36.8M 1.72%
26,841
– –
WIFI
16
DELISTED
Boingo Wireless, Inc.
WIFI
$30.5M 1.43%
4,467,960
– –
NKTR icon
17
Nektar Therapeutics
NKTR
$2.35B
$23.4M 1.1%
121,707
– –
TRVN
18
DELISTED
Trevena, Inc.
TRVN
$21.5M 1.01%
6,099
– –
GYRE icon
19
Gyre Therapeutics
GYRE
$658M
$20.6M 0.97%
5,799
– –
FOLD
20
DELISTED
Amicus Therapeutics
FOLD
$18.9M 0.89%
5,653,029
– –
LXRX icon
21
Lexicon Pharmaceuticals
LXRX
$1.03B
$18.8M 0.88%
1,668,000
– –
DZSI
22
DELISTED
DZS Inc. Common Stock
DZSI
$14.8M 0.7%
956,258
– –
ECOM
23
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$14.7M 0.69%
556,692
– –
ALIM
24
DELISTED
Alimera Sciences
ALIM
$13.5M 0.63%
150,376
– –
OREX
25
DELISTED
Orexigen Therapeutics, Inc.
OREX
$12M 0.56%
193,530
– –
1
2

Similar funds

NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.76B AUM 13.06% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
PWP
Principle Wealth Partners Madison, Connecticut $1.75B AUM 21.63% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $1.77B AUM 31.28% 1-Year Est. Return

NEA Management Company's Q2 2014 Portfolio in Review

As of Q2 2014, NEA Management Company held 31 positions worth $2.13B, up 4.6% from $2.04B the previous quarter. Its ten largest holdings account for 78% of the portfolio.

NEA Management Company deployed $215M of net new capital in Q2 2014, opening 3 new positions. Its largest new stake was OPOWER INC COM STK (DE): 8,997,290 shares worth $170M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 51% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was HYPERION THERAPEUTICS INC COM STK (DE), an estimated $12.9M trimmed.

  • NEA Management Company's largest Q2 2014 buy was OPOWER INC COM STK (DE): 8,997,290 shares worth $170M.
  • NEA Management Company's biggest Q2 2014 reduction was HYPERION THERAPEUTICS INC COM STK (DE), cutting an estimated $12.9M.
  • NEA Management Company's ten largest holdings make up 78% of its $2.13B portfolio in Q2 2014.
  • NEA Management Company opened 3 new positions and closed 0 in Q2 2014.
  • NEA Management Company's portfolio value rose 4.6% quarter-over-quarter to $2.13B.

Based on NEA Management Company's 13F filing for Q2 2014, filed 31 Jul 2014.